| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $6.3B | $5.8B | $4.4B | $4.1B | $3.2B | $2.4B | $3.6B |
| Cost of Revenue | $3.7B | $3.3B | $2.5B | $2.4B | $1.6B | $1.4B | $2.2B |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | $0.5B | $0.4B | $0.6B | $0.9B | $0.9B | $0.9B | $1.5B |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $-0.2B | $-0.1B | $-0.5B | $-1.5B | $-1.1B | $-1.8B | $-2.7B |
| Net Income | $2.8B | $0.0B | $-0.3B | $-1.6B | $-1.0B | $-1.8B | $-2.6B |
| EPS (Basic) | $6.92 | $0.06 | $-0.88 | $-4.47 | $-3.02 | — | — |
| EPS (Diluted) | $6.81 | $0.06 | $-0.88 | $-4.47 | $-3.02 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B | $5.4B | $4.6B | $4.6B | $4.8B | $4.7B | $5.7B |
| Current Assets | $2.9B | $3.0B | $2.6B | $2.6B | $2.8B | $2.6B | $3.2B |
| Cash & Equivalents | $1.1B | $0.8B | $0.6B | $0.3B | $0.5B | $0.3B | $0.4B |
| Total Liabilities | $5.8B | $4.7B | $4.0B | $4.2B | $3.4B | $3.0B | $2.8B |
| Current Liabilities | $4.5B | $3.9B | $3.0B | $3.1B | $2.5B | $2.1B | $2.5B |
| Stockholders' Equity | $3.3B | $0.8B | $0.5B | $0.4B | $1.4B | $1.7B | $2.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.8B | $-0.1B | $-0.2B | $-0.1B | $-1.4B | $-0.1B |
| Investing Cash Flow | $0.4B | $-0.5B | $0.6B | $0.2B | $0.3B | $0.7B | $-1.6B |
| Capital Expenditures | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $0.5B | $1.6B |